Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 3,905.00
-70.00 (-1.76%)
At close: Feb 13, 2026
Korea Arlico Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -1,371 | -5,358 | 3,061 | 8,034 | 4,930 | 8,372 |
Depreciation & Amortization | 5,355 | 6,615 | 4,772 | 3,113 | 2,606 | 2,030 |
Loss (Gain) From Sale of Assets | -337.27 | -392.92 | -9.08 | 313.88 | -964.68 | 198.54 |
Loss (Gain) From Sale of Investments | -7.37 | -240.36 | -190.71 | -168.93 | -30.37 | -24.67 |
Stock-Based Compensation | - | - | - | - | 40.17 | 116.28 |
Provision & Write-off of Bad Debts | 9.63 | 1,390 | 126.29 | 237.65 | -10.88 | 18.28 |
Other Operating Activities | 1,588 | 1,132 | -1,585 | 984.83 | 889.17 | 722.56 |
Change in Accounts Receivable | -7,686 | -9,102 | -2,604 | -827.32 | -81.67 | 738.62 |
Change in Inventory | -1,055 | -6,475 | 987.01 | -7,508 | -2,018 | -6,399 |
Change in Accounts Payable | 483.5 | 2,474 | 44.89 | -305.18 | 1,746 | -1,443 |
Change in Income Taxes | 523.19 | - | - | - | - | - |
Change in Other Net Operating Assets | 4,300 | 1,373 | 2,545 | 962.68 | 1,861 | 216.43 |
Operating Cash Flow | 1,802 | -8,583 | 7,148 | 4,836 | 8,967 | 4,546 |
Operating Cash Flow Growth | - | - | 47.80% | -46.07% | 97.25% | -65.39% |
Capital Expenditures | -2,275 | -3,501 | -23,385 | -18,974 | -5,268 | -9,389 |
Sale of Property, Plant & Equipment | 381.26 | 1,029 | 9.11 | 45.95 | 43.43 | 10,458 |
Sale (Purchase) of Intangibles | 534.29 | -78.8 | -135.15 | -3,434 | 352.82 | -630.35 |
Investment in Securities | 449.55 | 8,432 | -3,622 | 13,742 | -7,737 | 6,099 |
Other Investing Activities | -124.76 | -46.55 | -117.48 | -299.48 | 6,471 | 128.72 |
Investing Cash Flow | -2,034 | 4,834 | -27,250 | -8,919 | -6,137 | 6,666 |
Short-Term Debt Issued | - | 47,898 | 56,109 | 5,796 | 2,826 | - |
Long-Term Debt Issued | - | 2,000 | 12,998 | 13,633 | - | 2,000 |
Total Debt Issued | 30,749 | 49,898 | 69,107 | 19,429 | 2,826 | 2,000 |
Short-Term Debt Repaid | - | -36,738 | -49,218 | - | - | -12,696 |
Long-Term Debt Repaid | - | -10,776 | -2,179 | -342.25 | -95.02 | -4,555 |
Total Debt Repaid | -26,408 | -47,514 | -51,398 | -342.25 | -95.02 | -17,251 |
Net Debt Issued (Repaid) | 4,341 | 2,384 | 17,710 | 19,087 | 2,731 | -15,251 |
Issuance of Common Stock | - | - | - | - | - | 267.88 |
Repurchase of Common Stock | - | - | - | - | -566.07 | -837.77 |
Dividends Paid | -1,126 | -1,952 | -1,952 | -1,051 | -957.6 | -1,917 |
Other Financing Activities | 0 | -270 | - | 19 | -56.34 | - |
Financing Cash Flow | 3,215 | 162.53 | 15,758 | 18,055 | 1,151 | -17,737 |
Foreign Exchange Rate Adjustments | 132.25 | 4.54 | 15.39 | -96.27 | 32.47 | -9.48 |
Net Cash Flow | 3,116 | -3,582 | -4,329 | 13,876 | 4,013 | -6,535 |
Free Cash Flow | -472.28 | -12,085 | -16,237 | -14,137 | 3,699 | -4,843 |
Free Cash Flow Margin | -0.23% | -6.35% | -8.68% | -8.43% | 2.64% | -3.88% |
Free Cash Flow Per Share | -31.50 | -804.92 | -551.67 | -936.13 | 245.38 | -321.05 |
Cash Interest Paid | 1,694 | 1,493 | 807.52 | 599.28 | 278.98 | 663.56 |
Cash Income Tax Paid | 2,159 | 548.79 | 1,565 | 758.08 | 1,758 | 2,004 |
Levered Free Cash Flow | -695.88 | -14,241 | -19,870 | -16,738 | 2,647 | -7,641 |
Unlevered Free Cash Flow | 619.73 | -12,926 | -18,878 | -16,133 | 2,820 | -7,242 |
Change in Working Capital | -3,435 | -11,730 | 973.18 | -7,678 | 1,508 | -6,887 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.